Amaria RN, Haymaker C, Forget M-A, et al. TGF-β dominant negative receptor (TGF-DNRII) and NGFR-transduced tumour infiltrating lymphocytes (TIL) and high dose interleukin-2 (IL-2) in patients (pts) with metastatic melanoma (MM). SMR 2017, abstract SMR04-1.
Apatinib versus placebo bij radioactief jodium-refractair gedifferentieerd schildkliercarcinoom
mei 2022 | Hoofd-halsoncologie